Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

NCT01059565 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Burkholderia Infections

Interventions

DRUG: AZLI
DRUG: Placebo

Sponsor

Gilead Sciences